BioVendor Group
BioVendor Group is a privately-held Czech biotechnology group founded in 1992 that develops, manufactures, and distributes in vitro diagnostic products across immunoassays, NGS cancer panels, antibodies, recombinant proteins, and endotoxin detection, serving research and clinical laboratories worldwide through six subsidiary brands.
- Company typePrivate
- Founded1992
- HeadquartersBrno, Czechia
- Headcount51–100
- GTM typeB2B
- OfferingHardware or Manufacturing
What BioVendor Group does
BioVendor Group is a privately-held international group of biotechnology companies headquartered in Brno, Czech Republic, founded in 1992. The group develops, manufactures, and distributes in vitro diagnostic (IVD) products and technologies spanning multiple diagnostic modalities, including immunoassays (ELISA and CLIA kits), recombinant proteins, monoclonal and polyclonal antibodies, Next Generation Sequencing (NGS) cancer panels (fastGEN and epicGEN lines), endotoxin detection products (ENDONEXT™ EndoZyme®), PCR/qPCR reagents, point-of-care testing devices (Bi-Reader, Bi-VirTest), and immunohistochemistry reagents. The technology platform is anchored in immunoassay and recombinant protein production capabilities, with proprietary innovations such as SophoMer™ F10, a synthetic polymer intended to replace BSA in laboratory assays. The group operates through six wholly-owned subsidiary brands (BioVendor-LM, BioVendor-RD, TestLine, ViennaLab, DiaSource, BioVendor MDx) plus three joint projects (CLIA CZ, MBA Microblot-Array, NGS CZ), serving academic and pharmaceutical research laboratories, clinical diagnostic laboratories, and oncology testing facilities worldwide.
The business model is primarily a one-time product-sale model with unit-based pricing, predominantly for Research Use Only (RUO) reagents. Pricing signals indicate per-unit economics on the order of $231–$300 for ELISA kits and $243–$1,890 for antibodies. Go-to-market is executed through direct sales via the corporate website and email/phone ordering, supplemented by a dedicated US distribution branch (BioVendor, LLC), regional distributors in other geographies, and a marketing mix that emphasizes trade-show presence (e.g., ADLM 2026, WHX Labs Dubai 2026), corporate website content, email newsletters, and LinkedIn. Customer segmentation is horizontal across research institutions, clinical labs, and oncology testing; no named anchor customers or enterprise contracts are disclosed. The M&A track record (TestLine 2012, Immunolab 2014, DIAsource 2017) and a 2014 capital injection from Accession Capital Partners indicate a roll-up strategy supported by external capital.
BioVendor Group firmographics
Firmographics- Name
- BioVendor Group
- Legal name
- BioVendor – Laboratorni medicina s.r.o.
- Website
- https://biovendor.com
- Company type
- Private
- Founded year
- 1992
- Operating status
- Operating
- Headcount range
- 51–100 employees
- Short description
- BioVendor Group is a privately-held Czech biotechnology group founded in 1992 that develops, manufactures, and distributes in vitro diagnostic products across immunoassays, NGS cancer panels, antibodies, recombinant proteins, and endotoxin detection, serving research and clinical laboratories worldwide through six subsidiary brands.
- Ownership category
- akta.pro rank
Where BioVendor Group is headquartered
LocationHeadquarters
- HQ city
- Brno
- HQ country
- Czechia
- HQ region
- Europe
Offices2 records
Markets served
BioVendor Group business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Personnel, Technology or R&D, Operations, Supply Chain, Marketing or Sales, Infrastructure
Revenue model
- IVD Products and Technologies: Sale of immunodiagnostic and molecular diagnostic products including immunoassays, antibodies, recombinant proteins, NGS kits, and laboratory reagents to research institutions, diagnostic laboratories, and healthcare facilities
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Unit Pricing | Pay-as-you-go | Human Fibrin Mouse Monoclonal Antibody - Research Use Only |
| Unit Pricing | Pay-as-you-go | Cartilage Oligomeric Matrix Protein Human ELISA - Discount pricing |
| Unit Pricing | Pay-as-you-go | Connective Tissue Growth Factor Human Antibodies |
| Unit Pricing | Pay-as-you-go | NT-proBNP Human, Sheep Polyclonal Antibody |
Distribution channels3 records
Marketing channels4 records
BioVendor Group product offering
Product offeringCore offering
BioVendor Group develops, manufactures, and distributes in vitro diagnostic (IVD) products and laboratory reagents for research and clinical diagnostics. Its portfolio spans immunoassays (ELISA, CLIA), Next Generation Sequencing (NGS) kits for cancer diagnostics, recombinant proteins, monoclonal and polyclonal antibodies, immunohistochemistry reagents, endotoxin detection assays, DNA/RNA extraction kits, qPCR reagents, and microRNA detection products. The group sells these validated diagnostic tools and laboratory reagents to research institutions, diagnostic laboratories, and healthcare facilities worldwide through multiple subsidiary brands.
Product overview
BioVendor Group is an international group of biotechnology companies focusing on the development, production, and distribution of IVD (In Vitro Diagnostic) products and technologies for laboratory automation. The product portfolio is organized into multiple core categories including Immunoassays (ELISA kits), Point of Care Testing (POCT), Next Generation Sequencing (NGS with fastGEN and epicGEN product lines), Proteins, Antibodies, Immunohistochemistry, Endotoxin Detection Products (ENDONEXT™), Tissue Engineering, DNA/RNA Extraction Kits, qPCR Reagents, and microRNA products. The offerings include both standalone reagent kits (like the Human COMP ELISA for cartilage research) and integrated solutions like the fully automated CLIA diabetes panel. The company serves research laboratories with validated diagnostic tools across immunoassays, molecular diagnostics, and Point of Care Testing segments.
Differentiator
Problem solved
Functional benefit
Brands
- CLIA CZ: Joint project focused on CLIA (chemiluminescence immunoassay) technology
- MBA
- NGS CZ
Products and services
- Immunoassays Validated ELISA and CLIA immunoassay kits for quantitative measurement of biomarkers including diabetes markers (C-peptide, Insulin, GAD65, IA-2), cardiovascular markers, and inflammation markers. Used by clinical and research laboratories.
- Point of Care Testing (POCT) Rapid point-of-care diagnostic tests including Bi-VirTest for Human MxA POCT for quick clinical diagnostics, along with associated readers such as Bi-Reader.
- Next Generation Sequencing (NGS) Kits - fastGEN and epicGEN NGS kits for cancer genotyping and molecular diagnostics including fastGEN Cancer Kits (MPN, EGFR/HER2, BCR::ABL1, MSI, H3F3A/IDH1/2, TERT, POLE/CTNNB1) and epicGEN Solid Cancer & MSI Kit. Used by cancer diagnostics laboratories.
- Recombinant Proteins Recombinant proteins including SARS-CoV-2 Nucleocapsid Protein, Uromodulin Human HEK293, Luteinizing Hormone, and Coagulation Factor VIII for research use.
- Antibodies Monoclonal and polyclonal antibodies including Human Fibrin, Human Fibrinogen, Connective Tissue Growth Factor, NT-proANP, and Neudesin antibodies for research applications including ELISA, Western blotting, immunohistochemistry, and flow cytometry.
- ENDONEXT™ EndoZyme® II Endotoxin Detection Products
Companies that use BioVendor Group
Customer profileSegments3 records
Ideal customer profiles3 records
BioVendor Group technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature5 records
BioVendor Group partnerships and signals
Strategic signalScale indicators2 records
BioVendor Group competitors and assessment
Company assessmentDirect peers
- DiaSorin: Italian IVD multinational focused on immunodiagnostics and molecular diagnostics, with comparable CLIA and ELISA reagent menus and a similar specialty-diagnostics positioning that competes head-to-head with BioVendor's immunoassay catalog.
- GenScript: Global biotech reagent company offering recombinant proteins, antibodies, gene synthesis, and molecular diagnostics reagents; comparable to BioVendor across protein/antibody and qPCR reagent lines.
- Euroimmun (Revvity): Specialist in autoimmune and infectious disease immunoassays, owned by Revvity; closely comparable to BioVendor's TestLine and BioVendor-LM subsidiaries in ELISA and Microblot-Array autoantibody testing.
- Abcam (Danaher): Major research antibody and recombinant protein supplier now owned by Danaher; directly competes with BioVendor-RD's antibody catalog and recombinant protein product lines in research applications.
- Qiagen: Leading molecular diagnostics and sample-prep company with overlapping offerings in DNA/RNA extraction kits, qPCR reagents, and NGS-targeted panels; directly competes with BioVendor MDx's molecular diagnostic kits.
- Surmodics / DiaPath (now part of broader portfolio): Provides IVD reagent chemistries and surface coatings used by diagnostic kit manufacturers, comparable in product category to BioVendor's reagent, antibody, and polymer reagent offerings for diagnostic workflows.
- LGC Group (SeraCare/Meridian Bioscience): Provides IVD reagents, diagnostic controls, and assay components; comparable to BioVendor's reagent and consumables business serving clinical and research labs globally.
Broad incumbents
- Merck KGaA / MilliporeSigma: Global life science tools and IVD reagent manufacturer with extensive antibody, protein, buffer, and assay kit portfolios; competes broadly with BioVendor across research reagent categories.
- Bio-Rad Laboratories: Large publicly traded life science and clinical diagnostics company with overlapping offerings in immunoassays, qPCR, NGS sample prep, and recombinant proteins; competes with BioVendor across multiple product categories but operates at vastly greater scale.
- Tecan: Swiss leader in lab automation and detection instruments (including CLIA readers used with BioVendor-type immunoassays); an incumbent whose automation platforms BioVendor kits run on, and which competes broadly for the lab reagent budget.
Market position
Strengths5 records
Weaknesses5 records
Key risks5 records
Key highlights6 records
Customer concentration
BioVendor Group social profiles
Digital presenceBioVendor Group financial estimates
Financial estimateRevenue estimate
Valuation estimate
BioVendor Group leadership team
Management profileNumber of profiles
Profiles3 records
BioVendor Group subsidiaries and ownership
Company hierarchySubsidiaries6 records
BioVendor Group funding detail
Funding detailFunding overview
Funding rounds1 record
Investors1 record
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
BioVendor Group M&A and investment
M&A and investmentM&A3 records
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about BioVendor Group
What does BioVendor Group do?
BioVendor Group develops, manufactures, and distributes in vitro diagnostic (IVD) products and laboratory reagents for research and clinical diagnostics. Its portfolio spans immunoassays (ELISA, CLIA), Next Generation Sequencing (NGS) kits for cancer diagnostics, recombinant proteins, monoclonal and polyclonal antibodies, immunohistochemistry reagents, endotoxin detection assays, DNA/RNA extraction kits, qPCR reagents, and microRNA detection products. The group sells these validated diagnostic tools and laboratory reagents to research institutions, diagnostic laboratories, and healthcare facilities worldwide through multiple subsidiary brands.
Is BioVendor Group a public or private company?
BioVendor Group is a private company. It is classified as private equity controlled and is currently operating.
When was BioVendor Group founded?
BioVendor Group was founded in 1992. It employs 51 to 100 people.
Where is BioVendor Group based?
BioVendor Group is headquartered in Brno, Czechia, in the Europe region.
How does BioVendor Group make money?
One revenue line is on record: IVD Products and Technologies.
Who are BioVendor Group's main competitors?
Direct peers on record are DiaSorin, GenScript, Euroimmun (Revvity), Abcam (Danaher), Qiagen, Surmodics / DiaPath (now part of broader portfolio) and LGC Group (SeraCare/Meridian Bioscience). Broad incumbents are Merck KGaA / MilliporeSigma, Bio-Rad Laboratories and Tecan.
Does BioVendor Group have an API?
No public API is recorded for BioVendor Group.